Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871832 · ClinicalTrials.gov registry record
Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality
A clinical trial of Hyperglycemia, sponsored by Northwell Health.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00871832: Completed study of Hyperglycemia, sponsored by Northwell Health.
NCT00871832 is a study of Hyperglycemia that has completed, run by Northwell Health. The registered enrollment target is 200 participants, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00871832, a study of Hyperglycemia, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
It is currently standard of care in many Medical and Surgical ICU's to institute a nurse driven insulin protocol in maintaining tight glucose control in the critical patient. Many articles have been written to address this topic. However, there is no current data regarding the use of glycohemoglobin as a marker of risk of morbidity and mortality. In our study we would like to determine whether or not the HbA1C could be used as a marker of morbidity and mortality. The HbA1C is a simple blood test that may be added on to any CBC collection tube; a blood sample that critical patients have drawn up to several times a day. The investigators would analyze this information in respect to the rest of the clinical data collected regarding the patient's illness.
Primary Outcome
looking to see if HbA1C correlates with morbidity (i.e. sepsis, renal failure, length of stay) or death
Conditions Studied
Study Locations (1)
New York
- Staten Island University Hospital - Staten Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-03 |
What the finished NCT00871832 record still lists
NCT00871832 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 0 interventions.
NCT00871832 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00871832 about?
NCT00871832 is a clinical study titled "Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality". It is currently standard of care in many Medical and Surgical ICU's to institute a nurse driven insulin protocol in maintaining tight glucose control in the critical patient. Many articles have been written to address this topic. However, there is no current data regarding the use of glycohemoglobin...
What is the current status of trial NCT00871832?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2007-05. Estimated completion is 2010-03.
What conditions does trial NCT00871832 study?
This clinical trial studies the following conditions: Hyperglycemia.
Who is sponsoring clinical trial NCT00871832?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00871832 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00871832's enrollment target sits among peer trials
200 10th of 38 higher than 27 of 38 other Hyperglycemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
-
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia